Published in Br J Cancer on April 07, 2003
4-Bromo-methyl-6-meth-oxy-2H-chromen-2-one. Acta Crystallogr Sect E Struct Rep Online (2010) 1.07
BF3·Et2O Catalysed 4-Aryl-3-phenyl-benzopyrones, Pro-SERMs, and Their Characterization. Adv Pharmacol Sci (2015) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
The hallmarks of cancer. Cell (2000) 113.05
New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer (2002) 24.71
Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science (2002) 12.29
Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res (1986) 5.05
The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer (1997) 5.01
The determination of the concentration of hydrolytic enzyme solutions: alpha-chymotrypsin, trypsin, papain, elastase, subtilisin, and acetylcholinesterase. J Am Chem Soc (1966) 3.09
Angiogenesis and tumor metastasis. Annu Rev Med (1998) 3.08
Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. J Biol Chem (2001) 2.56
Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J Biol Chem (2000) 2.50
Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J (1993) 2.28
Mouse Aortic Ring Assay: A New Approach of the Molecular Genetics of Angiogenesis. Biol Proced Online (2002) 1.91
Immunology of spontaneous mammary carcinomas in mice. V. Acquired tumor resistance and enhancement in strain A mice infected with mammary tumor virus. Cancer Res (1966) 1.87
Invasion of reconstituted basement membrane matrix is not correlated to the malignant metastatic cell phenotype. Cancer Res (1991) 1.83
Improved quantification of angiogenesis in the rat aortic ring assay. Angiogenesis (2001) 1.29
Reaction of serine proteases with aza-amino acid and aza-peptide derivatives. Methods Enzymol (1977) 1.04
Basement membrane components (matrigel) promote the tumorigenicity of human breast adenocarcinoma MCF7 cells and provide an in vivo model to assess the responsiveness of cells to estrogen. Biochem Pharmacol (1992) 1.00
Inhibition of sCD23 and immunoglobulin E release from human B cells by a metalloproteinase inhibitor, GI 129471. Immunology (1998) 0.86
Cloning of choriocarcinoma cells shows that invasion correlates with expression and activation of gelatinase A. Exp Cell Res (1996) 0.81
Inactivation of human high- and low-molecular-weight urokinases. Analysis of their active site. Biochim Biophys Acta (1984) 0.78
Coumarinic derivatives as mechanism-based inhibitors of alpha-chymotrypsin and human leukocyte elastase. Bioorg Med Chem (2000) 0.78
6-Substituted 2-oxo-2H-1-benzopyran-3-carboxylic acid as a core structure for specific inhibitors of human leukocyte elastase. J Med Chem (1999) 0.78
Paradoxical stimulation of matrix metalloproteinase-9 expression in HT1080 cells by a broad-spectrum hydroxamate-based matrix metalloproteinase inhibitor. Ann N Y Acad Sci (1999) 0.78
Irreversible inhibition and peptide mapping of urinary plasminogen activator urokinase. FEBS Lett (1982) 0.77
Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med (1998) 2.54
Regulation of vimentin by SIP1 in human epithelial breast tumor cells. Oncogene (2006) 2.09
An overview of inhibitors of Na(+)/H(+) exchanger. Eur J Med Chem (2003) 2.02
In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J Cell Biol (1998) 1.95
The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies. J Cell Biol (2001) 1.94
Study of the influence of both cyclodextrins and L-lysine on the aqueous solubility of nimesulide; isolation and characterization of nimesulide-L-lysine-cyclodextrin complexes. J Pharm Sci (1997) 1.62
A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer. Oncogene (2011) 1.38
MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines. Cell Death Dis (2013) 1.37
P-glycoprotein inhibition by glibenclamide and related compounds. Pflugers Arch (1999) 1.35
MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol (2000) 1.33
Endovascular treatment of intracranial aneurysms with a branch arising from the sac. AJNR Am J Neuroradiol (2006) 1.29
Improved quantification of angiogenesis in the rat aortic ring assay. Angiogenesis (2001) 1.29
Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization. FASEB J (2001) 1.29
Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis. Cancer Res (2001) 1.18
High levels of TIMP-2 correlate with adverse prognosis in breast cancer. Int J Cancer (2000) 1.16
Comparative analysis of the intracellular localization of c-Myc, c-Fos, and replicative proteins during cell cycle progression. Mol Cell Biol (1992) 1.16
Presence of oestrogen receptor type beta in human retina. Br J Ophthalmol (2001) 1.15
Adverse obstetrical outcomes after treatment of precancerous cervical lesions: a Belgian multicentre study. BJOG (2012) 1.14
Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC). Br J Cancer (2006) 1.11
Role of plasminogen activator-plasmin system in tumor angiogenesis. Cell Mol Life Sci (2003) 1.10
Synthesis and anticonvulsant activity of 2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives. J Med Chem (1998) 1.09
Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer. Br J Cancer (1998) 1.07
Fetal growth restriction: a workshop report. Placenta (2004) 1.03
Stromelysin-3: a paradigm for stroma-derived factors implicated in carcinoma progression. Crit Rev Oncol Hematol (1997) 1.03
Inhibition of matrix metalloproteinase 2 maturation and HT1080 invasiveness by a synthetic furin inhibitor. FEBS Lett (1998) 1.03
Quality assurance in radiotherapy: the importance of medical physics staffing levels. Recommendations from an ESTRO/EFOMP joint task group. Radiother Oncol (1996) 1.03
Membrane type 1 matrix metalloproteinase-associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines. J Biol Chem (2000) 1.02
Induction of endothelial cell apoptosis by solid tumor cells. Exp Cell Res (1998) 1.01
Type IV collagen induces matrix metalloproteinase 2 activation in HT1080 fibrosarcoma cells. Exp Cell Res (2000) 1.00
Matrix metalloproteinases and TIMP-1 production by peripheral blood granulocytes from COPD patients and asthmatics. Allergy (2001) 0.99
Induction of SPARC by VEGF in human vascular endothelial cells. Biochem Biophys Res Commun (2001) 0.99
Proteasome inhibitors: recent advances and new perspectives in medicinal chemistry. Curr Top Med Chem (2010) 0.98
MT1-MMP protects breast carcinoma cells against type I collagen-induced apoptosis. Oncogene (2011) 0.98
Macrophage migration inhibitory factor (MIF) expression in human glioblastomas correlates with vascular endothelial growth factor (VEGF) expression. Neuropathol Appl Neurobiol (2002) 0.97
Combined magnetic resonance imaging- and positron emission tomography-guided stereotactic biopsy in brainstem mass lesions: diagnostic yield in a series of 30 patients. J Neurosurg (2000) 0.97
Esophageal cancer: determination of internal target volume for conformal radiotherapy. Radiother Oncol (2006) 0.96
Human chorionic gonadotropin and growth factors at the embryonic-endometrial interface control leukemia inhibitory factor (LIF) and interleukin 6 (IL-6) secretion by human endometrial epithelium. Hum Reprod (2004) 0.94
A polymorphism (5-HTTLPR) in the serotonin transporter promoter gene is associated with DSM-IV depression subtypes in seasonal affective disorder. Mol Psychiatry (2003) 0.94
Alteration of interendothelial adherens junctions following tumor cell-endothelial cell interaction in vitro. Exp Cell Res (1997) 0.93
Radioimmunotherapy with radioactive nanoparticles: biological doses and treatment efficiency for vascularized tumors with or without a central hypoxic area. Med Phys (2010) 0.93
Two genes contribute to different extents to the heme oxygenase enzyme activity measured in cultured human skin fibroblasts and keratinocytes: implications for protection against oxidant stress. Photochem Photobiol (1995) 0.93
Urine protein 1: a sex-dependent marker of tubular or glomerular dysfunction. Clin Chem (1989) 0.92
Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided stereotactic biopsy. Cancer (1996) 0.92
Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy. J Nucl Med (1997) 0.92
Lipopeptides as dimerization inhibitors of HIV-1 protease. Biol Chem (1999) 0.91
Altered expression of angiogenesis and lymphangiogenesis markers in the uninvolved skin of plaque-type psoriasis. Br J Dermatol (2008) 0.91
Functionalized N-aryl azetidinones as novel mechanism-based inhibitors of neutrophil elastase. FEBS Lett (1991) 0.89
beta-Amyloid protein aggregation: its implication in the physiopathology of Alzheimer's disease. Pathol Biol (Paris) (2001) 0.89
New trends in thromboxane and prostacyclin modulators. Curr Med Chem (2000) 0.88
Prevention of epidural fibrosis in a prospective series of 100 primary lumbo-sacral discectomy patients: follow-up and assessment at re-operation. Neurol Res (1999) 0.88
The metalloproteinase ADAM-12 regulates bronchial epithelial cell proliferation and apoptosis. Cell Prolif (2008) 0.88
PET findings in a brain abscess associated with a silent atrial septal defect. Clin Neurol Neurosurg (1995) 0.88
Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose. J Neurosurg (1995) 0.88
Crystal structure of the catalytic domain of MMP-16/MT3-MMP: characterization of MT-MMP specific features. J Mol Biol (2004) 0.88
Design and synthesis of hydrazinopeptides and their evaluation as human leukocyte elastase inhibitors. J Med Chem (1998) 0.87
Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo. Br J Cancer (2002) 0.87
Cavernous haemangioma in the cavernous sinus: case report and review of the literature. Neuroradiology (2001) 0.87
Radioimmunotherapy with radioactive nanoparticles: first results of dosimetry for vascularized and necrosed solid tumors. Med Phys (2007) 0.86
Dialogue between blastocyst hCG and endometrial LH/hCG receptor: which role in implantation? Gynecol Obstet Invest (2007) 0.86
[CyberKnife robotic stereotactic radiotherapy: technical aspects and medical indications]. Cancer Radiother (2007) 0.86
An alternative strategy for inhibiting multidrug-resistant mutants of the dimeric HIV-1 protease by targeting the subunit interface. Biochem Soc Trans (2007) 0.85
Nuclear delivery of a therapeutic peptide by long circulating pH-sensitive liposomes: benefits over classical vesicles. Int J Pharm (2011) 0.85
[Anemia prevalence in pregnant and breast-feeding women in Lubumbashi (Democratic Republic of the Congo). Impact of malaria and intestinal helminthiasis]. J Gynecol Obstet Biol Reprod (Paris) (2003) 0.85
The IGF system in in-vitro human decidualization. Mol Hum Reprod (2008) 0.85
3-(Alkylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as powerful inhibitors of insulin release from rat pancreatic B-cells: a new class of potassium channel openers? J Med Chem (1993) 0.85
Dosimetric consequences of breath-hold respiration in conformal radiotherapy of esophageal cancer. Phys Med (2007) 0.85
Stromelysin-3 in the biology of the normal and neoplastic mammary gland. J Mammary Gland Biol Neoplasia (1996) 0.84
Sarcoidosis presenting as an isolated intramedullary tumor. Neurosurgery (1991) 0.84
Additional parameters for the morphometry of angiogenesis and lymphangiogenesis in corneal flat mounts. Exp Eye Res (2009) 0.84
Hydroxylation, sulfation, and conjugation of bile acids in rat hepatoma and hepatocyte cultures under the influence of glucocorticoids. J Biol Chem (1980) 0.84
Modulators of the coagulation cascade: focus and recent advances in inhibitors of tissue factor, factor VIIa and their complex. Curr Med Chem (2005) 0.84
Progression in MCF-7 breast cancer cell tumorigenicity: compared effect of FGF-3 and FGF-4. Breast Cancer Res Treat (2000) 0.83
An atypical infectious complication of anterior cervical surgery. Neuroradiology (1997) 0.83
Development of an animal experimental model to study the effects of levonorgestrel on the human endometrium. Hum Reprod (2008) 0.83
Evaluation of in vitro reconstituted basement membrane assay to assess the invasiveness of tumor cells. Invasion Metastasis (1992) 0.83
High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma. Histopathology (2008) 0.82
In vitro effects of estetrol on receptor binding, drug targets and human liver cell metabolism. Climacteric (2008) 0.82
New mechanism-based inactivators of trypsin-like proteinases. Selective inactivation of urokinase by functionalized cyclopeptides incorporating a sulfoniomethyl-substituted m-aminobenzoic acid residue. J Med Chem (1993) 0.82
Production and activation of matrix metalloprotease-9 (MMP-9) by HL-60 promyelocytic leukemia cells. Biochem Biophys Res Commun (1997) 0.82
Purification of active matrix metalloproteinase catalytic domains and its use for screening of specific stromelysin-3 inhibitors. Protein Expr Purif (1999) 0.82
3-and 4-substituted 4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as potassium channel openers: synthesis, pharmacological evaluation, and structure-activity relationships. J Med Chem (1996) 0.81
Interaction of human leukocyte elastase with a N-aryl azetidinone suicide substrate: Conformational analyses based on the mechanism of action of serine proteinases. J Mol Graph (1996) 0.81
Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors. Bioorg Med Chem (2010) 0.81
Design, synthesis, and evaluation of conformationally constrained tongs, new inhibitors of HIV-1 protease dimerization. J Med Chem (1999) 0.81
Novel inhibitors of the sodium-calcium exchanger: benzene ring analogues of N-guanidino substituted amiloride derivatives. Eur J Med Chem (2001) 0.81
New trends in the design of drugs against Alzheimer's disease. Curr Med Chem (2004) 0.81
Inhibitory effect of curcuminoids and tetrahydrocurcuminoids on equine activated neutrophils and myeloperoxidase activity. Physiol Res (2007) 0.81
Cyclodextrins as a potential carrier in drug nebulization. J Control Release (2004) 0.81
Unusual CT features of dermoid cyst in the posterior fossa. Eur Radiol (2002) 0.81